AEye (LIDR) Appoints Conor Tierney as CFO

AEye, Inc. (NASDAQ: LIDR), a global leader in adaptive, high-performance lidar solutions, today announced that Conor Tierney has been appointed Chief Financial Officer and Treasurer. Tierney joined AEye as Chief Accounting Officer in January 2022 and most recently served as the company’s Interim Chief Financial Officer.

“I am pleased to welcome Conor Tierney to our executive team as Chief Financial Officer,” said Matt Fisch, Chief Executive Officer of AEye. “Conor joined AEye in 2022, with twenty years of financial leadership and management experience with top technology companies, including Alphabet and Glu Mobile. Since joining AEye, Conor has demonstrated his deep financial acumen and knowledge of technology, and he will be a valuable asset to AEye as we focus on executing against our go-forward strategic plan.”

Previously, Tierney was Chief Accounting Officer at AEye, responsible for overall leadership of the company’s accounting, financial compliance, controls, and reporting functions. Prior to joining AEye, Tierney was Head of Finance and Corporate Controller at Alphabet’s (Nasdaq: GOOG) Wing Aviation division (Alphabet’s drone delivery business). He also served as Corporate Controller at Glu Mobile (Nasdaq: GLUU) in the mobile gaming space, managing a global team, and worked in public accounting at “Big Four” firms including Deloitte and PricewaterhouseCoopers. Conor graduated with a BSc in Accounting from University College Cork and is a Certified Public Accountant.

“I’m delighted to take on the CFO role,” said Tierney. “AEye’s unique capital efficient licensing model and strategy stand out in the lidar space, and as we move forward with our partner, Continental, to commercialize AEye’s advanced automotive applications, I see great opportunity to create value for our stakeholders.”

You May Also Be Interested In

• Atlassian (TEAM) comes ahead of Street estimates in Q1 but shares tumble
• T-Mobile posts mixed Q1 top and bottom line, expects more subscribers in 2024
• Biogen (BIIB) Receives Positive CHMP Opinion for TOFIDENCE